Kon‐Siong G. Jie

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 922 citations · Full text

Hematological Malignancy, Radiation Oncology, Medicine +9

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman et al. · Blood · 2009 · 275 citations · Full text

Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial

Pascale Notten, Arina J. ten Cate‐Hoek, Carsten W. K. P. Arnoldussen et al. · The Lancet Haematology · 2019 · 212 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +11

Effect of food composition on vitamin K absorption in human volunteers

Birgit L. M. G. Gijsbers, Kon‐Siong G. Jie, Cees Vermeer · British Journal Of Nutrition · 1996 · 168 citations · Full text

Nutrition, Nutraceutical Ingredient, Vitamin K Absorption +17

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Philippe Moreau, Cyrille Hulin, Aurore Perrot et al. · The Lancet Oncology · 2021 · 167 citations · Full text

Hematological Malignancy, Medicine, Autologous Stem-cell Transplant +6